{"entity":{"id":"clario","kind":"company","name":"Clario","aka":[],"tldr":"Clario is the endpoint technology company (Bioclinica and ERT merger) for imaging, eCOA, and cardiac data in trials.","summary":"Clario, based in Philadelphia, is the endpoint technology company formed from the merger of Bioclinica and ERT, covering imaging, electronic clinical outcome assessment and cardiac data in trials. Its services span central review of medical imaging, electronic clinical outcome assessments and respiratory and cardiac endpoints. OnCo links it to imaging core labs and central review and to clinical trial software. Whether one vendor collecting imaging, patient-reported and cardiac endpoints together improves trial data quality, or concentrates risk, is the open question. The imaging core lab technology page carries the wider picture.","asOf":"2026-09-08","links":[{"label":"Official website","url":"https://clario.com"}],"tags":["supporting"],"related":[],"cancers":[],"sections":["imaging","ai-computation"],"technologies":["imaging-core-labs","clinical-trial-software"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":["nct05642780"],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"hq":"Philadelphia, PA","country":"US","companyType":"cro-services","website":"https://clario.com","investors":[],"funding":[]},"route":"/companies/clario/","neighbours":{"section":[{"id":"ai-computation","kind":"section","name":"AI & Computation","route":"/fronts/ai-computation/"},{"id":"imaging","kind":"section","name":"Imaging","route":"/fronts/imaging/"}],"technology":[{"id":"clinical-trial-software","kind":"technology","name":"Clinical trial software (EDC, eCOA, CTMS, RTSM)","route":"/technologies/clinical-trial-software/"},{"id":"imaging-core-labs","kind":"technology","name":"Imaging core labs and central review","route":"/technologies/imaging-core-labs/"}],"trial":[{"id":"nct05642780","kind":"trial","name":"SKB264 in Combination With Pembrolizumab in Subjects With Selected Solid Tumors","route":"/trials/nct05642780/"}]}}